健康栄養医学研究室

膵疾患に関する研究業績

  1. 慢性膵炎C.診断機能検査　診断体系と診断基準、鑑別診断　石黒　洋、成瀬　達　膵疾患へのアプローチ（下瀬川　徹　編）中外医学社P.98-104, 2008.
  2. 慢性膵炎　病理・病態生理　石黒　洋、水野伸匡、近藤孝晴　新しい診断と治療のABC消化器8膵炎・膵癌（下瀬川　徹　編）最新医学社P.73-79, 2008.
  3. Allochronic biliary strictures appeared in the different regions of the bile duct tree in a patient with autoimmune pancreatitis. Ko SB, Naruse S, Ishiguro H, Yoshikawa T, Yamamoto T, Futakuchi S, Goto H. Pancreas 34:479-81, 2007.
  4. Is genetic analysis helpful for diagnosing chronic pancreatitis in its early stage? Naruse S, Fujiki K, Ishiguro H. J Gastroenterol 42 Suppl 17:60-5, 2007.
  5. 急性膵炎、重症急性膵炎　蛋白分解酵素阻害薬の有効性は？　石黒　洋、成瀬　達　臨床に直結する肝・胆・膵疾患治療のエビデンス （文光堂 東京）222-224, 2007.
  6. CFTRの機能異常と慢性膵炎　石黒　洋、近藤孝晴、山本明子、成瀬　達　Annual Review消化器2007（林　紀夫　他　編）中外医学社P.213－219, 2007.
  7. アルコール代謝酵素の遺伝子多型と膵機能障害　石黒　洋、藤木理代、中莖みゆき、山本明子、成瀬　達、近藤孝晴　呼気生化学の進歩10:68-76, 2007.
  8. Fecal pancreatic elastase: a reproducible marker for severe exocrine pancreatic insufficiency. Naruse S, Ishiguro H, Ko SB, Yoshikawa T, Yamamoto T, Yamamoto A, Futakuchi S, Goto H, Saito Y, Takahashi S. J Gastroenterol 41:901-8, 2006
  9. 慢性膵炎の発症機序－腺房細胞と導管細胞の視点から　石黒　洋、成瀬　達、近藤孝晴、山本明子　治療学40:41-44, 2006.
  10. A finger sweat chloride test for the detection of the high-risk group of chronic pancreatitis. Naruse S, Ishiguro H, Suzuki Y, Fujiki K, Ko SBH, Mizuno N, Takemura T, Yamamoto A, Yoshikawa T, Jin C, Suzuki R, Kitagawa M, Tsuda T, Kondo T, Hayakawa T. Pancreas 28:e80-e85, 2004.
  11. Genetic evidence for CFTR dysfunction in Japanese: background for chronic pancreatitis. Fujiki K, Ishiguro H, Ko SBH, Mizuno N, Suzuki Y, Takemura T, Yamamoto A, Yoshikawa T, Kitagawa M, Hayakawa T, Sakai Y, Takayama T, Saito M, Kondo T, Naruse S. J Med Genet 41:e55, 2004.
  12. アルコールによる膵障害発生機序の最近の考え方は？　石黒　洋、山本明子、藤木理代、中莖みゆき、洪　繁、吉川俊之、後藤秀実、 近藤孝晴、成瀬　達　胆と膵25（臨時増刊号）:816-819, 2004.
  13. Clinical evidence of pathogenesis in chronic pancreatitis. Hayakawa T, Naruse S, Kitagawa M, Ishiguro H, Jin CX, Kondo T. J Hepatobiliary Pancreat Surg 9:669-74, 2002.
  14. 膵外分泌機能検査　石黒　洋、成瀬　達、早川哲夫　臨床医のための膵炎Basic & Clinical Science（大槻　眞　編） 現代医療社P.26-29, 2002
  15. Insulinoma with subsequent association of Zollinger-Ellison syndrome. Mizuno N, Naruse S, Kitagawa M, Ishiguro H, Ito O, Ko SB, Yoshikawa T, Tanahashi C, Ito M, Hayakawa T. Intern Med 40:386-90, 2001.
  16. Urinary excretion of trypsinogen activation peptide (TAP) in taurocholate-induced pancreatitis in rats. Wang Y, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Hayakawa T. Pancreas 22:24-7, 2001.
  17. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats. Naruse S, Wang Y, Kitagawa M, Ishiguro H, Seki Y, Ozaki T, Hayakawa T. Pancreas 21:290-5, 2000.
  18. Do plasma and urine trypsinogen activation peptides (TAP) really increase in trypsin-taurocholate-induced pancreatitis? Wang Y, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Yoshikawa T, Hayakawa T. Pancreas 20:389-93, 2000.
  19. Effect of a new inhibitor of type II phospholipase A2 on experimental acute pancreatitis in rats. Yoshikawa T, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Ono T, Hayakawa T. Pancreas 19:193-8, 1999.
  20. A prospective multicenter trial evaluating diagnostic validity of multivariate analysis and individual serum marker in differential diagnosis of pancreatic cancer from benign pancreatic diseases. Hayakawa T, Naruse S, Kitagawa M, Ishiguro H, Kondo T, Kurimoto K, Fukushima M, Takayama T, Horiguchi Y, Kuno N, Noda A, Furukawa T. Int J Pancreatol 25:23-9, 1999.
  21. Molecular forms of serum pancreatic stone protein in acute pancreatitis. Nakae Y, Naruse S, Kitagawa M, Ishiguro H, Kato M, Hayakawa S, Kondo T, Hayakawa T. Int J Pancreatol 25:17-21, 1999.
  22. Molecular understanding of chronic pancreatitis: a perspective on the future. Naruse S, Kitagawa M, Ishiguro H. Mol Med Today 5:493-9, 1999.
  23. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats. Wang Y, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Yoshikawa T, Hayakawa T. Pancreas 17:289-94, 1998.
  24. Islet cell tumor in von Hippel-Lindau disease. Mizuno N, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Ieda H, Iizuka N, Ito O, Seki Y, Ko SB, Yoshikawa T, Hayakawa T, Sano T, Kamiya J, Nimura Y, Nagasaka T. Intern Med 37:295-9, 1998.
  25. Pharmaceutical development for treating pancreatic diseases. Kitagawa M, Naruse S, Ishiguro H, Hayakawa T. Pancreas 16:427-31, 1998.
  26. Chronic pancreatitis: overview of medical aspects. Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Kondo T, Hayakawa T. Pancreas 16:323-8, 1998.
  27. Evaluating exocrine function tests for diagnosing chronic pancreatitis. Kitagawa M, Naruse S, Ishiguro H, Nakae Y, Kondo T, Hayakawa T. Pancreas 15:402-8, 1997.
  28. Change of pancreatic enzymes, pancreatic stone protein (PSP), and plasma α2-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice. Kato M, Hayakawa S, Naruse S, Kitagawa M, Ishiguro H, Nakae Y, Hayakawa T. Pancreas 15:345-9, 1997.
  29. 慢性膵炎の経過と予後　早川哲夫、成瀬　達、北川元二、石黒　洋、中江康之　現代医療29:68-74, 1997.
  30. Cerulein-induced acute pancreatitis diminished vitamin E concentration in plasma and increased in the pancreas. Antosiewicz J, Popinigis J, Ishiguro H, Hayakawa T, Wakabayashi T. Int J Pancreatol 17:231-6, 1995.
  31. Serum alpha 2-macroglobulin-trypsin complex and early recognition of severe acute pancreatitis after endoscopic retrograde pancreatography. Nakae Y, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H, Ishiguro H, Tanikawa M. J Gastroenterol Hepatol 9:272-6, 1994
  32. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis. Sobajima H, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Ishiguro H, Tanikawa M, Nakae Y. Digestion 55:90-6, 1994.
  33. 膵外分泌機能検査としてのBT-PABA・PAS試験の有用性　石黒　洋、早川哲夫、近藤孝晴、成瀬　達、柴田時宗、北川元二、中江康之、 神部隆吉、片田直幸、傍島裕司、鈴木敏行　膵臓9(4):298-304, 1994
  34. Longitudinal changes of plasma pancreatic enzymes and hormones in experimental pancreatolithiasis in dogs. Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sobajima H, Sakai Y, Ishiguro H, Nakae Y, Tanikawa M, Naruse S. Dig Dis Sci 38:2098-103, 1993.
  35. Effect of a new synthetic trypsin inhibitor on taurocholate-induced acute pancreatitis in rats. Sobajima H, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Ishiguro H, Tanikawa M, Nakae Y. Pancreas 8:240-7, 1993.
  36. Pancreatic stone predominantly composed of fatty acid calcium. Kitagawa M, Hayakawa T, Kondo T, Shibata T, Sakai Y, Sobajima H, Ishiguro H, Tanikawa M, Nakae Y, Nimura Y, et al. Gastroenterology 102:2151-4, 1992.
  37. 膵石症に合併した膵癌の一例　石黒　洋、早川哲夫、近藤孝晴、柴田時宗、北川元二、酒井雄三、傍島裕司、中江康之、 谷川　誠、二村雄次、神谷順一、近藤　哲、待木雄一　 <膵臓7(2):77-82, 1992.
  38. Elevation of serum phospholipase A2 in patients at an intensive care unit. Kitagawa M, Hayakawa T, Kondo T, Shibata T, Sakai Y, Sobajima H, Ishiguro H, Tanikawa M, Nakae Y, Kameya S, et al. Int J Pancreatol 10:279-86, 1991.
  39. The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases. Kitagawa M, Hayakawa T, Kondo T, Shibata T, Sakai Y, Sobajima H, Ishiguro H, Nakae Y. Gastroenterol Jpn 26:62-8, 1991.
  40. Exocrine pancreatic function in chronic liver diseases. Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H, Ishiguro H, Nakae Y, Kato K. Am J Gastroenterol 86:201-4, 1991.

研究と業績トップ｜膵疾患に関する研究内容｜膵疾患に関する研究業績

Copyright© 2005 Laboratory of Human Nutrition. All Rights Reserved.
Created by MMS-NET